100.45 Healthcare Resource Utilization and Costs Among Patients Receiving Cangrelor or Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention in the United States

JACC: Cardiovascular Interventions 2026

View at publisher

Authors: Siyu Ma

DOI: 10.1016/j.jcin.2026.01.045

Cited by: 0

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Coronary Interventions and Diagnostics Acute Myocardial Infarction Research